Abstract
BackgroundRecent data have suggested that serum uric acid (SUA) level is positively associated with the development of type 2 diabetes (T2DM). Whether SUA is also independently associated with the development of vascular complications and mortality in T2DM is controversial.MethodsA computerized literature search of MEDLINE, Embase and PubMed database was conducted and the odds ratio (OR) or hazard ratio (HR) for per 0.1mmol/l increase in SUA in each study was calculated. Cochrane’s Q and I2 statistics were used to evaluate heterogeneity among studies and pooling OR and HR with 95% confidence intervals (CIs) were calculated using random-effects models and fixed-effects models. The pooled analysis was performed using Stata 10.0.ResultsOur search yielded 9 eligible articles (16 ORs and HRs) including 20,891 T2DM patients. Pooled estimates for the relationship suggested that each 0.1 mmol/l increase in SUA resulted in a 28% increase in the risk of diabetic vascular complications and a 9% increase in the risk of diabetic mortality. In stratification-analysis, the positive relationship between SUA and vascular complications remained significant irrespective of mean age, adjustment for metabolic variables and medications. However, it was inconsistent in different populations (significantly positive in the Asian but not in Australian and Italian population) and sample sizes (significantly positive in the relatively large sample size [≥1000] but non-significant in the small sample size [<1000]).ConclusionsResults of this meta-analysis supported elevated SUA as an independent predictor of vascular complications and mortality in T2DM patients. SUA-lowering therapies might be helpful for prevention and treatment of vascular complications in this population.
Highlights
Type 2 diabetes mellitus (T2DM) is undoubtedly one of the most challenging health problems in the 21st century and the number of diabetic patients diagnosed has reached 366 million in 2011 [1]
Of the remaining 13 articles, only one provided hazard ratio (HR) of the association of serum uric acid (SUA) and diabetic nephropathy, one provide HR of the association of SUA and diabetic cardiovascular diseases, which cannot be combined with odds ratio (OR), two of them could not be used in our meta-analysis
Another 2 articles were excluded because one of them was in Chinese and the unit for SUA increase was unavailable in another one
Summary
Type 2 diabetes mellitus (T2DM) is undoubtedly one of the most challenging health problems in the 21st century and the number of diabetic patients diagnosed has reached 366 million in 2011 [1]. Two recent meta-analysis revealed that elevated SUA has been an independent risk factor for the development of type 2 diabetes (T2DM) [6,7]. Recent data have suggested that serum uric acid (SUA) level is positively associated with the development of type 2 diabetes (T2DM). In stratification-analysis, the positive relationship between SUA and vascular complications remained significant irrespective of mean age, adjustment for metabolic variables and medications. It was inconsistent in different populations (significantly positive in the Asian but not in Australian and Italian population) and sample sizes (significantly positive in the relatively large sample size [≥1000] but non-significant in the small sample size [
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
